Nurtec ODT Backing RWR Eurasia At Rolex 24

MOORESVILLE, N.C. – Biohaven Pharmaceuticals announced Tuesday that Nurtec ODT will be the primary sponsor on the No. “We are really excited to join the field for the 24 Hours of Daytona this year,” said team co-owner Rick Ware. “Being a part of the 24 Hours of Daytona is another first for us as we continue to support innovative programs to drive awareness of migraine disease and the importance of acute treatment.”. Nurtec ODT was approved by the U.S. Food and Drug Administration for the acute treatment of migraine in February 2020 and is the first and only CGRP receptor antagonist available in an orally disintegrating tablet (ODT).

Follow MotorMouth on social media:
Liked it? Take a second to support Motormouth on Patreon!
Notify of
Inline Feedbacks
View all comments

Please Sign-in / Sign-up to see more content, unlock more features, and take part in MotorMouth discussions!

Would love your thoughts, please comment.x

Forgot your details?

Create Account